Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1674 1681
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18355108 | Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18316084 | INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION | Non-Final OA | Therapeutic Solutions International, Inc. |
| 18272116 | SYNERGISTIC EFFECT OF A FXR AGONIST AND IFN FOR THE TREATMENT OF HBV INFECTION | Non-Final OA | UNIVERSITÉ CLAUDE BERNARD LYON 1 |
| 18281216 | IMMUNOMODULATORY MOLECULES AND USES THEREOF | Non-Final OA | Immunowake Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy